VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.

Uzunoglu, F G; Kolbe, J; Wikman, H; Güngör, C; Bohn, B A; Nentwich, M F; Reeh, M; König, A M; Bockhorn, M; Kutup, A; Mann, O; Izbicki, J R; Vashist, Y K

Uzunoglu, F G; Kolbe, J; Wikman, H; Güngör, C; Bohn, B A; Nentwich, M F; Reeh, M; König, A M; Bockhorn, M; Kutup, A; Mann, O; Izbicki, J R; Vashist, Y K.

Affiliation

Uzunoglu FG; Department of General, Visceral and Thoracic Surgery, University Medical Center of Hamburg-Eppendorf, Martinistr. 52, 20246Hamburg, Germany. vashist@uke.de

Ann Oncol ; 24(5): 1282-90, 2013 May.

Article in En | MEDLINE | ID: mdl-23293110

Subject(s)

Pancreatic Neoplasms/genetics; Pancreatic Neoplasms/mortality; Receptor, PAR-1/genetics; Receptors, Interleukin-8B/genetics; Vascular Endothelial Growth Factor Receptor-2/genetics; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/genetics; Disease-Free Survival; Female; Genotype; Humans; Male; Middle Aged; Neovascularization, Pathologic/genetics; Pancreatic Neoplasms/surgery; Polymorphism, Single Nucleotide; Survival; Pancreatic Neoplasms

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Receptors, Interleukin-8B / Vascular Endothelial Growth Factor Receptor-2 / Receptor, PAR-1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google